Johnson & Johnson has only a few million COVID-19 vaccine doses in stock as likely launch nears (reuters.com)

Sounds like Johnson & Johnson didn't do as much "at risk scaling" of its vaccine manufacturing as Pfizer and Moderna did.

tags: $jnjcovid19vaccinepharma

posted by matt in Wednesday, February 17, 2021